normally used in heart surgery, to give it a separate blood supply.The limb is then heated to 39C, the most effective temperature for drug treatment.A powerful new drug called TNF alpha which breaks down the vessels supplying blood to cancerous tumours is then injected into the bloodstream of...
Targeted therapy and immunotherapy, have also given doctors more tools to fight cancer. Immunotherapy uses the body’s immune system to recognise and fight cancer cells. “Because of these trends,” said Dr Khoo Kei Siong, “we suspect that cancer treatment will become increasingly ...
A QIMR Berghofer study has identified how a newly approved blood cancer drug works and found the treatment is better than other drugs at targeting cancer stem cells while causing minimal damage to healthy cells. The long-acting form of thedrugInterferon alpha was approved for use in Australia in...
The drug is to be evaluated as a treatment for osteoporosis, but may also prevent the development of breast and endometrial cancer in a broad group of... VC Jordan - 《Breast Cancer Research & Treatment》 被引量: 2097发表: 1995年 Delivery of molecular and cellular medicine to solid tumors...
A new drug has been approved to battle mantle cell lymphoma, an aggressive cancer often fatal because of its resistance to treatment, after a study led by a Hackensack University Medical Center physician showed it can stop the progression of the disease in about a quarter of the patients. ...
with six achieving a complete response. In the otherstudy, researchers at the University of Pennsylvania gave a combination therapy to patients with metastatic non-small cell lung cancer as a first-line treatment. Typically, the response rate of these patients to Keytruda alone is about 45%, but...
It is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation, the FDA said on Friday. Patients are selected for treatment with Lynparza based on an FDA-approved genetic test. ...
Before, this treatment was done in the hospital, and the patient was required to spend 48 to 72 hours in isolation, to avoid exposure of radiation to others."Another plus of the Micro Selectron, Graham said, is that it allows the medical staff to perform the treatment from behind a ...
STAT Plus: Johnson & Johnson seeks first drug approval for treatment of smoldering myeloma Health Angus Chen STAT Plus: Early treatment may delay or prevent multiple myeloma in high-risk patients, according to new study Pharma Andrew Joseph STAT Plus: GSK myeloma medicine improves survival in...
I really hope to revolutionisetreatmentfor patients. I didn't get in this game to generate long lists of priority targets, I want to make a difference in a patient's life. Even a handful of new, more effective anti-cancer drugs in the clinic or an improvement in the drug development pr...